Sunny Pharmtech has signed a contract with a British pharmaceutical company to collaborate in developing the Carboprost injection MENA market. It is expected to start small-scale shipments with the United Arab Emirates government tender in 2024 Q2, and gradually launch in other countries such as Saudi Arabia and North Africa by 2026. The Carboprost injection market in the Middle East is estimated to be worth 8 million dollars annually.